JPS527960A - Novel isoxazol derivatives and production thereof - Google Patents
Novel isoxazol derivatives and production thereofInfo
- Publication number
- JPS527960A JPS527960A JP51065476A JP6547676A JPS527960A JP S527960 A JPS527960 A JP S527960A JP 51065476 A JP51065476 A JP 51065476A JP 6547676 A JP6547676 A JP 6547676A JP S527960 A JPS527960 A JP S527960A
- Authority
- JP
- Japan
- Prior art keywords
- novel
- production
- isoxazol
- derivatives
- isoxazol derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2524959A DE2524959C2 (en) | 1975-06-05 | 1975-06-05 | 5-methyl-isoxazole-4-carboxylic acid anilides, process for their preparation, agents containing these compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS527960A true JPS527960A (en) | 1977-01-21 |
JPS5938230B2 JPS5938230B2 (en) | 1984-09-14 |
Family
ID=5948292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51065476A Expired JPS5938230B2 (en) | 1975-06-05 | 1976-06-04 | Novel isoxazole derivatives and their production method |
Country Status (15)
Country | Link |
---|---|
US (1) | US4087535A (en) |
JP (1) | JPS5938230B2 (en) |
AT (1) | AT349007B (en) |
BE (1) | BE842689A (en) |
CA (1) | CA1076584A (en) |
CH (1) | CH603608A5 (en) |
DK (1) | DK151013C (en) |
ES (1) | ES448386A1 (en) |
FR (1) | FR2313052A1 (en) |
GB (1) | GB1547452A (en) |
IE (1) | IE43136B1 (en) |
IT (1) | IT1063592B (en) |
LU (1) | LU75077A1 (en) |
MX (1) | MX3144E (en) |
NL (1) | NL178596C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54102196U (en) * | 1977-12-28 | 1979-07-18 | ||
JPS6398092A (en) * | 1986-10-14 | 1988-04-28 | 富士電機株式会社 | Card balance settler for gold note |
JP2009280604A (en) * | 1997-08-08 | 2009-12-03 | Sanofi-Aventis Deutschland Gmbh | Method for producing crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazol-4-carboxamide |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2654797A1 (en) * | 1976-12-03 | 1978-06-08 | Hoechst Ag | PROCESS FOR THE PREPARATION OF ISOXAZOLE DERIVATIVES |
DE2854439A1 (en) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | AN ISOXAZOLE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF, AGENT AND USE THEREOF |
ATE14724T1 (en) * | 1979-06-11 | 1985-08-15 | Ciba Geigy Ag | ALPHACARBAMOYL-PYRROLPROPIONITRILES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS. |
DE2940189A1 (en) * | 1979-10-04 | 1981-04-16 | Basf Ag, 6700 Ludwigshafen | ISOXAZOLYLCARBONIC ACID ANILIDE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS FUNGICIDES |
FR2538806B1 (en) * | 1982-12-30 | 1986-02-21 | Bago Sa Labor | PHENYL-3 METHYL ISOXAZOLE-5 CARBOXY-4 COMPOUNDS SUBSTITUTED ANILIDES, THERAPEUTICALLY ACTIVE INFLAMMATION AND PAIN |
US4935434A (en) * | 1988-01-26 | 1990-06-19 | Bristol-Myers Company | Antiarthritic isoxazole-4-carboxamides |
DD297328A5 (en) | 1989-08-18 | 1992-01-09 | �������@���������k���Kk�� | 5-METHYL-ISOXALOL-4-CARBONSAEANEANILIDE AND 2 HYDROXYETHYLIDENE CYANO ACID ACIDANILIDES FOR THE TREATMENT OF EYE DISEASES |
US5583150A (en) * | 1989-08-18 | 1996-12-10 | Alcon Laboratories, Inc. | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases |
US5001124A (en) * | 1990-02-02 | 1991-03-19 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
US5108999A (en) * | 1990-02-02 | 1992-04-28 | Syntex (U.S.A.) Inc. | 4-isoxazolecarboxamide derivatives |
DK0527736T3 (en) * | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazole-4-carboxylic acid amides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and the use of these drugs. |
DE4127737A1 (en) * | 1991-08-22 | 1993-02-25 | Hoechst Ag | MEDICINAL PRODUCTS FOR TREATMENT OF REPELLATION REACTIONS IN ORGAN PLANTING |
US6133301A (en) * | 1991-08-22 | 2000-10-17 | Aventis Pharma Deutschland Gmbh | Pharmaceuticals for the treatment of rejection reactions in organ transplantations |
GB9320299D0 (en) * | 1993-10-01 | 1993-11-17 | Roussel Lab Ltd | Isoxazole derivatives |
US6335356B1 (en) | 1994-01-07 | 2002-01-01 | Sugen, Inc. | Method of treating a patient by parenteral administration of a lipophilic compound |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
US5610173A (en) * | 1994-01-07 | 1997-03-11 | Sugen, Inc. | Formulations for lipophilic compounds |
US5624946A (en) * | 1994-07-05 | 1997-04-29 | Williams; James | Use of leflunomide to control and reverse chronic allograft rejection |
US5721277A (en) * | 1995-04-21 | 1998-02-24 | Sugen, Inc. | Compounds and methods for inhibiting hyper-proliferative cell growth |
US6331555B1 (en) | 1995-06-01 | 2001-12-18 | University Of California | Treatment of platelet derived growth factor related disorders such as cancers |
US6316479B1 (en) | 1997-05-19 | 2001-11-13 | Sugen, Inc. | Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders |
US7691890B2 (en) | 1998-03-11 | 2010-04-06 | James W. Williams | Anti-viral uses of leflunomide products |
US20050255071A1 (en) * | 1998-12-10 | 2005-11-17 | Aventis Pharma Deutschland Gmbh | Preparation having improved therapeutic breadth comprising nucleotide synthesis inhibitors |
GB0123571D0 (en) * | 2001-04-05 | 2001-11-21 | Aventis Pharm Prod Inc | Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis |
EP1935416A3 (en) | 2001-04-05 | 2008-10-22 | Aventis Pharma Inc | Use of (Z)-2-cyano-3-Hydroxy-but-2-enoic acid-(4'-trifluorromethylphenyl)-amide for treating multiple sclerosis |
US20050158371A1 (en) * | 2002-02-12 | 2005-07-21 | Sumitomo Pharmaceuticals Co., Ltd. | Novel external agent |
WO2005033103A1 (en) * | 2003-09-12 | 2005-04-14 | Rigel Pharmaceuticals, Inc. | Quinoline compounds and their uses |
WO2006004865A1 (en) * | 2004-06-29 | 2006-01-12 | Rigel Pharmaceuticals, Inc. | 2-substituted quinoline compounds and their uses as inhibitors of the ige receptor signaling cascade |
US20060024376A1 (en) * | 2004-07-30 | 2006-02-02 | The University Of Chicago | Methods and compositions for reducing toxicity associated with leflunomide treatment |
JOP20190207A1 (en) | 2017-03-14 | 2019-09-10 | Actelion Pharmaceuticals Ltd | Pharmaceutical combination comprising ponesimod |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK54063C (en) * | 1935-02-22 | 1937-12-27 | Hoffmann La Roche | Process for the preparation of dialkyl-substituted amides of isoxazole carboxylic acids. |
DE634286C (en) * | 1935-02-23 | 1936-08-26 | Hoffmann La Roche & Co Akt Ges | Process for the preparation of dialkyl-substituted amides of isoxazole carboxylic acids |
US2126329A (en) * | 1936-03-20 | 1938-08-09 | Hoffmann La Roche | Amide derivatives of isoxazole carboxylic acids |
DE673111C (en) * | 1938-01-18 | 1939-03-16 | Hoffmann La Roche & Co Akt Ges | Process for the preparation of amide-like offshoots of homologues of the isoxazole carboxylic acids |
US2288863A (en) * | 1940-02-27 | 1942-07-07 | Hoffmann La Roche | Process for the manufacture of substituted amides of 3,5-dimethylisoxazole-4-carboxylic acid |
DK58903C (en) * | 1940-02-27 | 1941-08-04 | Hoffmann La Roche | Process for the Preparation of Substituted Amides of 3,5-Dimethyl-Isoxazole-Carboxylic Acid- (4). |
-
1976
- 1976-05-31 NL NLAANVRAGE7605841,A patent/NL178596C/en not_active IP Right Cessation
- 1976-05-31 ES ES448386A patent/ES448386A1/en not_active Expired
- 1976-06-02 CH CH696276A patent/CH603608A5/xx not_active IP Right Cessation
- 1976-06-03 US US05/692,306 patent/US4087535A/en not_active Expired - Lifetime
- 1976-06-03 IT IT23923/76A patent/IT1063592B/en active
- 1976-06-03 LU LU75077A patent/LU75077A1/xx unknown
- 1976-06-04 GB GB23185/76A patent/GB1547452A/en not_active Expired
- 1976-06-04 CA CA254,134A patent/CA1076584A/en not_active Expired
- 1976-06-04 MX MX000270U patent/MX3144E/en unknown
- 1976-06-04 JP JP51065476A patent/JPS5938230B2/en not_active Expired
- 1976-06-04 IE IE1202/76A patent/IE43136B1/en unknown
- 1976-06-04 AT AT413776A patent/AT349007B/en not_active IP Right Cessation
- 1976-06-04 DK DK248376A patent/DK151013C/en not_active IP Right Cessation
- 1976-06-04 FR FR7617038A patent/FR2313052A1/en active Granted
- 1976-06-08 BE BE167707A patent/BE842689A/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54102196U (en) * | 1977-12-28 | 1979-07-18 | ||
JPS6398092A (en) * | 1986-10-14 | 1988-04-28 | 富士電機株式会社 | Card balance settler for gold note |
JP2009280604A (en) * | 1997-08-08 | 2009-12-03 | Sanofi-Aventis Deutschland Gmbh | Method for producing crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazol-4-carboxamide |
Also Published As
Publication number | Publication date |
---|---|
DK151013B (en) | 1987-10-12 |
BE842689A (en) | 1976-12-08 |
FR2313052A1 (en) | 1976-12-31 |
IT1063592B (en) | 1985-02-11 |
FR2313052B1 (en) | 1979-09-28 |
ES448386A1 (en) | 1978-04-16 |
DK151013C (en) | 1988-03-07 |
IE43136B1 (en) | 1980-12-31 |
DK248376A (en) | 1976-12-06 |
NL178596C (en) | 1986-04-16 |
US4087535A (en) | 1978-05-02 |
CA1076584A (en) | 1980-04-29 |
AT349007B (en) | 1979-03-12 |
JPS5938230B2 (en) | 1984-09-14 |
LU75077A1 (en) | 1977-03-09 |
IE43136L (en) | 1976-12-05 |
GB1547452A (en) | 1979-06-20 |
MX3144E (en) | 1980-05-09 |
CH603608A5 (en) | 1978-08-31 |
NL7605841A (en) | 1976-12-07 |
ATA413776A (en) | 1978-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS527960A (en) | Novel isoxazol derivatives and production thereof | |
AU1106076A (en) | Isoxazole derivatives | |
IL49706A0 (en) | Novel anhydro-vinca derivatives | |
JPS57145843A (en) | Aminoalcohol derivative and manufacture | |
JPS54119473A (en) | Novel dibenzopyrane intermediate and its manufacture | |
JPS5217468A (en) | Thiazolidine and production thereof | |
JPS5212118A (en) | Production of bicynalhydroester and bicynaldiester | |
IL49476A0 (en) | 2-amino-2-alkylthio-1-nitroethylenes and their production | |
ZA764847B (en) | 1,2-benzisoxazole derivatives and production thereof | |
JPS5210267A (en) | Production of ll pyrogulutamyllll prolineamide and production thereof | |
JPS5265280A (en) | Benzoxadinones and their production | |
GB1549342A (en) | 11-oxo-prostaglandin derivatives and processes for their manufacture | |
JPS5223071A (en) | Pyroline derivatives and production thereof | |
JPS51136664A (en) | Novel 33deoxyy14 betaa hydroxycaldenolide and production of the same | |
JPS51113898A (en) | 88aminootheophiline derivative * production and application thereof | |
IL50436A0 (en) | Novel 4-hydroxymethyl-2-pyrrolidinone derivatives and their production | |
NZ182426A (en) | Aroyl-phenylindene and aroyl-phenyl-naphthalene derivatives | |
IL50691A0 (en) | New isoxazoles and their manufacture | |
JPS5212163A (en) | Novel cerotonine derivatives | |
GB1517878A (en) | Morpholine derivatives and production thereof | |
JPS56103173A (en) | Novel dibenzopyrane intermediate and its manufacture | |
JPS51125379A (en) | Production of aminopyrole derivatives | |
JPS5257162A (en) | Azetidinee22ones and production thereof | |
JPS5223074A (en) | Hexahydroo2hhindazole derivatives and production thereof | |
JPS5219697A (en) | Compound and production thereof |